CD58 and diffuse large B-cell lymphoma: CD58 is markedly decreased, even lost, in many hematological malignancies, including diffuse large B-cell lymphoma, Burkitt’s lymphoma, chronic myelogenous leukemia, acute lymphoid leukemia [19–21].